eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


3/2012
vol. 11
 
Share:
Share:
abstract:
Original paper

Diagnostic value of glucose transporter 1 and 3 (GLUT1 and GLUT3) mRNA level in postmenopausal women with urinary bladder cancer

Anna Krześlak
,
Paweł Jóźwiak
,
Ewa Forma
,
Magdalena Bryś
,
Paweł Woźniak
,
Jacek Wikosz
,
Marek Lipiński
,
Waldemar Różański

Przegląd Menopauzalny 2012; 3: 178–182
Online publish date: 2012/07/04
View full text Get citation
 
Purpose: The aim of the study was to evaluate the usefulness of glucose transporters (GLUT1 and GLUT3) mRNA level for bladder cancer diagnosis in postmenopausal women.

Material and methods: Glucose transporters expression was measured by a real-time polymerase chain reaction (real-time PCR) assay in urine obtained from 46 postmenopausal women with bladder cancer and 37 healthy women.

Results: GLUT1 expression was found in urine of both healthy women (74%) and bladder cancer patients (82%). GLUT3 expression was not detected in urine of healthy persons but it was found in 62% of bladder cancer samples. A positive expression of poorly differentiated bladder cancers (G2, G3) showed a significantly higher GLUT1 expression than G1 tumors. Similarly, GLUT 3 transcript level was significantly higher in G2 and G3 in comparison to G1 bladder cancers. Analogous results were obtained for both genes in relation to the clinical stage (ta-T1 vs. T2-T4). There was no relationship between the expression of studied genes and recurrence.

Conclusions: Analysis of the glucose transporters expression in the urine of postmenopausal women with bladder cancer appears to be a useful diagnostic indicator of the disease.
keywords:

glucose transporters, GLUT1, GLUT3, bladder cancer

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.